发明名称 |
Controlled release pharmaceutical composition |
摘要 |
The present invention is drawn to a pharmaceutical composition characterized by containing a composition (A) which contains pitavastatin, a salt thereof, or an ester thereof and which initiates release thereof at least in the stomach, and an enteric composition (B) which contains pitavastatin, a salt thereof, or an ester thereof. By use of the controlled release pharmaceutical composition of the present invention, the blood level of pitavastatin can be maintained at an appropriate level immediately after administration over a long period of time. Thus, highly safety and effective treatment of hypercholesterolemia can be performed.
|
申请公布号 |
US2004018235(A1) |
申请公布日期 |
2004.01.29 |
申请号 |
US20030461432 |
申请日期 |
2003.06.16 |
申请人 |
KOWA CO., LTD;NISSAN CHEMICAL INDUSTRIES LIMITED |
发明人 |
TANIZAWA YOSHIO;SHIMOKAWA TATSUHARU;OGAWA HIROTADA;WATANABE MAYUMI;OHASHI CHIHIRO;KAWASHIMA HIROYUKI;SHINODA YASUO;INAGI TOSHIO |
分类号 |
A61K9/20;A61K9/22;A61K9/24;A61K9/50;A61K31/47;A61P3/06;A61P43/00;(IPC1-7):A61K31/366;A61K31/225 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|